Nanotechnology may better identify, treat ectopic pregnancy By Franny White November 21, 2022 Ectopic pregnancies are a leading cause in pregnancy-related deaths.
OHSU forecast projects severe strain on Oregon hospitals due to RSV By Erik Robinson November 18, 2022 Forecast projects RSV hospitalizations, including infants and toddlers, to peak on Nov. 30.
OHSU-developed brain surgery simulator proves valuable in nationwide test By Erik Robinson November 17, 2022 Akin to pilots training on pre-flight simulators, new simulator for brain surgeons appears to be feasible on a large scale.
Keeping children safe and healthy during RSV season November 17, 2022 A joint statement from Kaiser Permanente, Legacy Health, OHSU Health, Providence.
OHSU recibe a la primera residente de obstetricia y ginecología que llega de otro estado para capacitarse en atención de abortos By Nicole Rideout November 16, 2022 La médica residente llegó a Oregón desde un estado en el que el aborto está prohibido y por consiguiente no puede recibir la capacitación.
OHSU welcomes first out-of-state OB/GYN resident to receive training in abortion care By Nicole Rideout November 16, 2022 Physician-in-training came to Oregon from a state where abortion is banned, she’s unable to receive training.
Oregon governor declares RSV in children a public health emergency By Nicole Rideout November 15, 2022 OHSU Doernbecher, other hospitals in the region seeing a high number of sick children amid health care staffing challenges.
To help address nurse shortage, OHSU prepares new educators By Franny White November 11, 2022 Oregon Nursing Education Academy established to expand nurse faculty, preceptor ranks.
OHSU joins national pledge to reduce carbon emissions, make facilities resilient to climate change November 10, 2022 The Biden administration recognized OHSU, other health care leaders at COP27 international conference.
OHSU scientists identify molecule that could help treat Parkinson’s By Erik Robinson November 09, 2022 Discovery could immediately suggest new avenues for drug development.